• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Scotland

An elderly woman has a virtual visit with her doctor
MedTech

Current Health nabs $43M series B for telehealth platform

Still riding the wave of massive growth in 2020, Current Health closed an overstuffed funding round in support of its remote care management platform.
Andrea Park Apr 23, 2021 9:26am
Glowing Jellyfish

Calcivis nets FDA blessing for protein-powered dental imaging

Mar 9, 2020 7:50am
The Invizius team

Invizius nets £2.75M for its machine-cloaking protein solution

Oct 22, 2019 3:45pm
Pounds sterling

MGB tops up cash pool to wrap up antibiotic phase 2a

Aug 30, 2019 9:15am
A stethoscope and paper money

DYSIS Medical lands $25M to expand in U.S., U.K. and other markets

Jul 9, 2018 9:00am
Edinburgh - alice-photoiStockGetty Images PlusGetty Images

NuCana plans $115M IPO to test retooled chemotherapies

Sep 6, 2017 7:48am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings